General Information |
| Clinical trials phase |
Phase 1 |
| Start date (estimated) |
2025-05-11 |
| End date (estimated) |
2026-09-01 |
| Clinical feature |
| Label |
autism spectrum disorder |
| Link |
http://purl.obolibrary.org/obo/MONDO_0005258 |
| Description |
A spectrum of developmental disorders that includes autism, and Asperger syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors. |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2500102199 |
| Other study identifiers |
| Name |
ChiCTR2500102199 |
| Description |
Chinese Clinical Trial Registry |
|
| Source weblink |
https://www.chictr.org.cn/showproj.html?proj=264622 |
| Study sites |
|
| Sponsors |
The First Medical Center of the Chinese PLA General Hospital
|
Cells |
| Which differentiated cell type is used |
| Label |
Exosome |
| Link |
http://purl.obolibrary.org/obo/NCIT_C104457 |
| Description |
A secretory vesicle between 30 and 90 nm in diameter that can play a role in receptor recycling, plasma membrane protein shedding, and the secretion of proteins and RNA. |
|
Recruitment |
| Recruitment Status |
Recruiting |
| Comment recruitment status |
Dose escalation group:6;treatment group:15;control group:15 |
| Estimated number of participants |
36 |
